Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | CCR6 | P51684 | 1/20 | 0.51 |
| ▸ | F7 | P08709 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CASR | P41180 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Daimuron SCHEMBL65275 | 1.00 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL7904977 | 0.92 | RAB9A (0.52) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL2607688 | 0.91 | RAB9A (0.50) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL8709318 | 0.90 | SMN1; SMN2 (0.57) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL18079667 | 0.87 | LMNA (0.53) | MAPTALDH1A1LMNA | |
| SCHEMBL8606898 | 0.83 | HSD17B10 (0.53) | RAB9ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL28317115 | 0.82 | F7 (0.53) | MAPTALDH1A1LMNAF7 | |
| SCHEMBL16624883 | 0.82 | MAPT (0.63) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL2607504 | 0.82 | MAPT (0.73) | NPC1RAB9AMAPTALDH1A1LMNA | |
| Daimuron SCHEMBL9434861 | 0.81 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237644-A1 | OIL FLOWABLE APYRASE INHIBITOR FORMULATION | TEXAS CROP SCIENCE, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240156091-A1 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | TEXAS CROP SCIENCE, INC. | 2024-05-16 | — | — | US | disclosed |
| US-20240156090-A1 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | TEXAS CROP SCIENCE, INC. | 2024-05-16 | — | — | US | disclosed |
| US-20240099300-A1 | SULFONAMIDE APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | disclosed |
| US-20240101510-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | disclosed |
| EP-4338593-A1 | AGRICULTURAL AND HORTICULTURAL FUNGICIDAL COMPOSITION | Nippon Soda Co., Ltd. (JP) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024050040-A2 | APYRASE INHIBITORS | TEXAS CROP SCIENCE (US) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024050041-A2 | SULFONAMIDE APYRASE INHIBITORS | TEXAS CROP SCIENCE (US) | 2024-03-07 | — | — | WO | disclosed |
| CN-116867373-A | Herbicidal composition | 日本曹达株式会社 | 2023-10-10 | — | — | CN | disclosed |
| US-10968492-B2 | HPPD-inhibitor herbicide tolerance | PIONEER HI-BRED INTERNATIONAL, INC. | 2021-04-06 | — | — | US | disclosed |
| WO-1992013861-A1 | HERBICIDAL BICYCLIC ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-08-20 | — | — | WO | disclosed |
| WO-1992009587-A1 | HERBICIDAL OXAZINE ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009578-A1 | SUBSTITUTED FUSED HETEROCYCLIC HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992004827-A1 | HERBICIDAL SUBSTITUTED BICYCLIC TRIAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-02 | — | — | WO | disclosed |
| EP-0463054-A1 | SELECTIVE OXABICYCLOALKANES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-02 | — | — | EP | disclosed |
| WO-1991015478-A1 | CROP-SELECTIVE HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-17 | — | — | WO | disclosed |
| WO-1991010668-A1 | HERBICIDAL SULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-07-25 | — | — | WO | disclosed |
| WO-1991003464-A1 | HERBICIDAL OXABICYCLO ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-03-21 | — | — | WO | disclosed |
| WO-1990012012-A1 | SUBSTITUTED PHENYLTRIAZOLOPYRIMIDINE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-18 | — | — | WO | disclosed |
| WO-1990010634-A1 | SELECTIVE OXABICYCLOALKANES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240237644-A1 | OIL FLOWABLE APYRASE INHIBITOR FORMULATION | APEH, ACHE, ALOX5 | NPC1 3244/4885RAB9A 2621/4885SMN1; SMN2 2890/4885 |
| US-20240156090-A1 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | APEH, DNPEP, ACHE | NPC1 4654/4885RAB9A 2677/4885SMN1; SMN2 2119/4885 |
| US-20240156091-A1 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | CMA1, APEH, PM20D2 | NPC1 2943/4885RAB9A 2053/4885SMN1; SMN2 4244/4885 |
| US-20240101510-A1 | APYRASE INHIBITORS | APEH, DPEP1, PON1 | NPC1 2564/4885RAB9A 1387/4885SMN1; SMN2 4511/4885 |
| US-20240099300-A1 | SULFONAMIDE APYRASE INHIBITORS | APEH, ARSA, DNPEP | NPC1 3337/4885RAB9A 1777/4885SMN1; SMN2 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.